Melanoma vs the double-edged sword | 47 min
Immune checkpoint inhibitors have revolutionised care for patients with advanced melanoma, with around half of patients with unresectable metastatic melanoma living to five years...
Recent advances in the diagnosis and treatment of melanoma | 69 mins
In this presentation given at the Yale School of Medicine Dermatology Grand Rounds, world-leading melanoma pathologist, Prof Richard Scolyer AO, discusses: • MIA’s goals...
The evolving paradigm shift in melanoma | 45 min
The field of melanoma has experienced a paradigm shift in recent years, with advancements in both diagnosis and management driving improved patient outcomes. Through...
To shave or not to shave when biopsying melanoma | 18 min
‘To shave or not to shave, that is the question.’ In this engaging debate, Dermatologist A/Prof Victoria Mar and Surgeon Prof Michael Henderson present...
Non-melanoma skin cancers | 47 min
During this presentation, leading clinicians discuss the biology, assessment and treatment of non-melanoma skin cancers, including Merkel cell carcinoma, squamous cell carcinoma (SCC) and...
Neoadjuvant therapy in melanoma: The perfect model | 12 min
‘To shave or not to shave, that is the question.’ In this engaging debate, Dermatologist A/Prof Victoria Mar and Surgeon Prof Michael Henderson present...
Multidisciplinary management of in-transit melanoma | 28 min
Managing in-transit melanoma can be challenging, and it presents and progresses as a heterogeneous disease. Multidisciplinary care is recommended for this complex disease to...
The current role of sentinel node biopsy in the management of melanoma | 60 min
Identification and biopsy of the sentinel lymph node can help correctly indicate whether melanoma has spread beyond the primary site, which is one of...
Melanoma update with Georgina Long | 34 min
In this interview from Oncology News Australia, MIA’s Prof Georgina Long AO speaks with Dr Craig Underhill on a wide range of developments in...